A review of new science, in plain language

Nature Medicine  ·  13 July 2026  ·  From issue 08

A new targeted drug shrank tumors in many patients with an aggressive, spreading eye cancer.

Matteo S. Carlino, Ellen Kapiteijn et al., An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial, Nature Medicine.

Integrity screen: passed (3 checks) Checked 17 August 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 08 15 papers
More from Nature Medicine